Welcome to the HECAOD podcast! Today’s episode is hosted by Dr. Ken Hale, Associate Director of the Higher Education Center, with guest, Dr. Mark Sirgo, President and Chief Executive Officer of BioDelivery Sciences.
Please join Dr. Hale and Dr. Sirgo as they discuss the use of buprenorphine and medication assisted treatment in treating opioid use disorder.
Podcast Guest: Dr. Mark Sirgo
SAMHSA Advisory (2016) – Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update